High frequency mutations in TP53 drive high-grade serous ovarian cancers, and furthermore, high frequency TP53 mutations were important molecular phenotypes for the development of some poor prognostic subtypes in cancer (25). This evidence concerns the gene TP53 and ovarian serous adenocarcinoma.